This substudy will investigate the effectiveness of combination therapy consisting of antistaphylococcal cell-wall active agents plus adjunctive fosfomycin vs. standard monotherapy in patients with Staphylococcus aureus bloodstream infections at high risks of complications or relapse.
SNAP Trial
Daptomycin vs. Vancomycin for the Treatment of MRSA bacteremia
Profiling the genetic and epigenetic determinants that predispose to severe manifestations of Staphylococcus aureus bacteremia
Cell-free DNA is a Versatile Analyte to Monitor Complications and Guide Treatment Duration in Staphylococcus aureus Bacteremia
Derivation and Validation of Phenotypes of Staphylococcus aureus bloodstream infection, with Correlation with Outcome.
PK/PD of oral beta-lactam with and without probenecid for treatment of Staphylococcus aureus bacteraemia.
Significance of S. aureus bacteriuria in patients hospitalized with S. aureus bacteremia